Patents by Inventor Linda Mindeholm

Linda Mindeholm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17)
    Publication number: 20230331834
    Abstract: The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists. e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: January 9, 2023
    Publication date: October 19, 2023
    Inventors: Gerard Bruin, Shea Carter, Frank Kolbinger, Iain McInnes, Neal Millar, Linda Mindeholm, Matthias Schieker, Eckhard Weber
  • USE OF CANAKINUMAB
    Publication number: 20210371511
    Abstract: Use of an IL-1? inhibitor such as canakinumab for the treatment and/or prevention of osteoarthritis and complications related thereto.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 2, 2021
    Inventors: Linda MINDEHOLM, Jens PRAESTGAARD, Mattias SCHIEKER
  • METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17)
    Publication number: 20210179702
    Abstract: The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: November 1, 2018
    Publication date: June 17, 2021
    Inventors: Gerard Bruin, Shea Carter, Frank Kolbinger, Iain McInnes, Neal Millar, Linda Mindeholm, Matthias Schieker, Eckhard Weber
  • Pharmaceutical compositions comprising hGH for oral delivery
    Patent number: 8323688
    Abstract: The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: December 4, 2012
    Assignee: Novartis AG
    Inventors: Moise Azria, Yatindra Joshi, Rosario Lobrutto, Linda Mindeholm, Ashish B Patel
  • PHARMACEUTICAL COMPOSITIONS COMPRISING HGH FOR ORAL DELIVERY
    Publication number: 20100247608
    Abstract: The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith.
    Type: Application
    Filed: August 28, 2007
    Publication date: September 30, 2010
    Inventors: Moise Azria, Yatindra Joshi, Rosario Lobrutto, Linda Mindeholm, Ashish B. Patel